325 related articles for article (PubMed ID: 15767574)
1. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.
Rasia RM; Bertoncini CW; Marsh D; Hoyer W; Cherny D; Zweckstetter M; Griesinger C; Jovin TM; Fernández CO
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4294-9. PubMed ID: 15767574
[TBL] [Abstract][Full Text] [Related]
2. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex.
Bortolus M; Bisaglia M; Zoleo A; Fittipaldi M; Benfatto M; Bubacco L; Maniero AL
J Am Chem Soc; 2010 Dec; 132(51):18057-66. PubMed ID: 21141829
[TBL] [Abstract][Full Text] [Related]
4. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
[TBL] [Abstract][Full Text] [Related]
5. NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.
Fernández CO; Hoyer W; Zweckstetter M; Jares-Erijman EA; Subramaniam V; Griesinger C; Jovin TM
EMBO J; 2004 May; 23(10):2039-46. PubMed ID: 15103328
[TBL] [Abstract][Full Text] [Related]
6. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
[TBL] [Abstract][Full Text] [Related]
7. The role of His-50 of α-synuclein in binding Cu(II): pH dependence, speciation, thermodynamics and structure.
Valensin D; Camponeschi F; Luczkowski M; Baratto MC; Remelli M; Valensin G; Kozlowski H
Metallomics; 2011 Mar; 3(3):292-302. PubMed ID: 21212878
[TBL] [Abstract][Full Text] [Related]
8. Coordination abilities of N-terminal fragments of alpha-synuclein towards copper(II) ions: a combined potentiometric and spectroscopic study.
Kowalik-Jankowska T; Rajewska A; Wiśniewska K; Grzonka Z; Jezierska J
J Inorg Biochem; 2005 Dec; 99(12):2282-91. PubMed ID: 16203037
[TBL] [Abstract][Full Text] [Related]
9. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease.
Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094
[TBL] [Abstract][Full Text] [Related]
10. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?
De Ricco R; Valensin D; Dell'Acqua S; Casella L; Hureau C; Faller P
Chembiochem; 2015 Nov; 16(16):2319-28. PubMed ID: 26338312
[TBL] [Abstract][Full Text] [Related]
11. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
12. Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease.
Hong L; Simon JD
J Phys Chem B; 2009 Jul; 113(28):9551-61. PubMed ID: 19548659
[TBL] [Abstract][Full Text] [Related]
13. A revised picture of the Cu(II)-α-synuclein complex: the role of N-terminal acetylation.
Moriarty GM; Minetti CA; Remeta DP; Baum J
Biochemistry; 2014 May; 53(17):2815-7. PubMed ID: 24739028
[TBL] [Abstract][Full Text] [Related]
14. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
Drew SC
Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
[TBL] [Abstract][Full Text] [Related]
15. Copper(II) binding by fragments of alpha-synuclein containing M1-D2- and -H50-residues; a combined potentiometric and spectroscopic study.
Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z
Dalton Trans; 2006 Nov; (42):5068-76. PubMed ID: 17060993
[TBL] [Abstract][Full Text] [Related]
16. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ
J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470
[TBL] [Abstract][Full Text] [Related]
17. A doppel alpha-helix peptide fragment mimics the copper(II) interactions with the whole protein.
La Mendola D; Magrì A; Campagna T; Campitiello MA; Raiola L; Isernia C; Hansson O; Bonomo RP; Rizzarelli E
Chemistry; 2010 Jun; 16(21):6212-23. PubMed ID: 20411530
[TBL] [Abstract][Full Text] [Related]
18. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
19. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
20. Copper(I)-α-synuclein interaction: structural description of two independent and competing metal binding sites.
Camponeschi F; Valensin D; Tessari I; Bubacco L; Dell'Acqua S; Casella L; Monzani E; Gaggelli E; Valensin G
Inorg Chem; 2013 Feb; 52(3):1358-67. PubMed ID: 23343468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
